Scilex (SCLX)
Commercializes non-opioid treatments for acute and chronic pain.
$5.36
After-hours close−0.00 (−0.06%)
At close$5.36(+3.88%)
Something off on this page? Send us feedback.
Next report
Dec 2, 26
estimated · in 71 days
EPS estimate
−$0.08
Revenue estimate
$17.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Dec '26
Reported−$0.02−$2.26−$4.62−$13.80−$4.60−$4.76−$16.65Pending
Estimate−$0.10−$4.20−$0.57−$13.80−$0.29−$0.21−$0.18−$0.08
Surprise+77.4%+46.2%−715.4%0.0%−1,471.9%−2,166.5%−9,083.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Dec '26
Reported$14.9M$5.0M$9.9M$10.6M$4.8M$8.6M$7.6MPending
Estimate$17.8M$5.0M$26.3M$10.6M$12.1M$15.0M$16.0M$17.0M
Surprise−16.2%0.0%−62.3%0.0%−60.4%−42.6%−52.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $1.06 | — | — |
| Sep 2028 | $1.05 | — | — |
| Jun 2028 | $1.09 | — | — |
| Mar 2028 | $1.02 | — | — |
| Dec 2027 | $0.08 | — | — |
| Sep 2027 | $0.11 | — | — |
| Jun 2027 | $0.15 | — | — |
| Mar 2027 | $0.11 | — | — |
| Dec 2026 | −$0.09 | — | — |
| Dec 2026 | −$0.08 | — | — |
| Aug 2026 | −$0.18 | −$16.65 | −9,083.2% |
| May 2026 | −$0.21 | −$4.76 | −2,166.5% |
| Apr 2026 | −$0.29 | −$4.60 | −1,471.9% |
| Nov 2025 | −$13.80 | −$13.80 | 0.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Jan 2025 | |||
| Mar 2025 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $1.06 | — | — | $158.2M | — | — | — |
| Sep 2028 | $1.05 | — | — | $152.1M | — | — | — |
| Jun 2028 | $1.09 | — | — | $152.1M | — | — | — |
| Mar 2028 | $1.02 | — | — | $146.0M | — | — | — |
| Dec 2027 | $0.08 | — | — | $49.1M | — | — | — |
| Sep 2027 | $0.11 | — | — | $47.2M | — | — | — |
| Jun 2027 | $0.15 | — | — | $47.2M | — | — | — |
| Mar 2027 | $0.11 | — | — | $45.4M | — | — | — |
| Dec 2026 | −$0.09 | — | — | $18.0M | — | — | — |
| Dec 2, 2026 | −$0.08 | — | — | $17.0M | — | — | — |
| Aug 14, 2026 | −$0.18 | −$16.65 | −9,083.2% | $16.0M | $7.6M | −52.2% | +0.3% |
| May 20, 2026 | −$0.21 | −$4.76 | −2,166.5% | $15.0M | $8.6M | −42.6% | +0.5% |
| Apr 10, 2026 | −$0.29 | −$4.60 | −1,471.9% | $12.1M | $4.8M | −60.4% | −3.0% |
| Nov 14, 2025 | −$13.80 | −$13.80 | 0.0% | $10.6M | $10.6M | 0.0% | −1.0% |
| Aug 12, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Jan 17, 2025 | |||||||
| Mar 17, 2025 | |||||||
| Aug 13, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 11, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 7, 2023 | |||||||
| Sep 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |